Taltz Injection, Solution
Product Images NDC 0002-8905

Product Visual Gallery

This gallery contains 46 technical images submitted to the FDA as part of the official labeling for Taltz (NDC 0002-8905). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Taltz Uspi 1 V1)

A line graph depicting the percent of responders over 24 weeks, comparing TALTZ 80 mg Q4W (subcutaneous injection) treatment with placebo. The x-axis represents time in weeks, and the y-axis shows the percent of responders, illustrating higher response rates for TALTZ compared to placebo over time.*

FDA Label Image

Figure 2 (Taltz Uspi 2 V1)

This is a line graph titled ASAS40 showing the percentage of responders over time in weeks (0 to 16) on the x-axis and percent of responders (0 to 100) on the y-axis. Two data series are compared: TALZ 80 mg Q4W, depicted with triangles and a solid line, and Placebo, depicted with squares and a dotted line, showing increasing responder percentages over time with TALZ having higher response rates.*

FDA Label Image

Figure 3 (Taltz Uspi 3 V1)

A line graph titled ASAS40 showing the percent of responders over time in weeks. It compares TALTZ 80 mg Q4W (four-weekly) treatment with placebo. The TALTZ group is represented by a line with triangles, showing a higher and increasing responder percentage reaching about 35% by week 16. The placebo group is shown with a dotted line and squares, with a lower responder percentage peaking around 20% by week 16.*

FDA Label Image

Figure (Taltz Ai Ifu 1 V2)

An illustrated diagram of a TALTZ (ixekizumab) pre-filled injection pen, displaying the device with a white and green color scheme and a transparent section showing the liquid inside. The pen is designed for subcutaneous injection and includes visual indicators on the body of the device.*

FDA Label Image

Logo (Logo)

FDA Label Image

Figure (Taltz Ai Ifu 2 V3)

An instructional diagram of the TALTZ (ixekizumab) prefilled injection pen showing labeled parts including the injection button at the top, lock ring with lock/unlock symbols below, the medicine chamber in the middle, a clear base, and a twist-off base cap at the bottom with the needle end.*

FDA Label Image

Figure (Ifu 30 Min Clock)

An illustration of a clock showing 30 minutes, likely indicating a time interval or waiting period related to the product.*

FDA Label Image

Figure (Taltz Ai Ifu 3 V3)

An instructional illustration showing a hand holding a TALTZ (ixekizumab) injection pen. The diagram highlights the location of the expiration date on the pen, indicated by an arrow and a red circle around the blacked-out date area.*

FDA Label Image

Figure (Ifu Injection Sites)

An instructional diagram showing preferred subcutaneous injection sites on the human body for TALTZ (ixekizumab) injection. The highlighted areas include the abdomen, front thighs, and the back of the upper arms, illustrated on both front and back views of a human figure.*

FDA Label Image

Figure (Taltz Ai Ifu 4 V2)

An instructional illustration showing a hand holding a TALTZ injection pen with a focus on a green dial or cap. The diagram highlights a rotational arrow near the dial, indicating the direction to turn, accompanied by lock and unlock icons to guide proper usage of the injection device.*

FDA Label Image

Figure (Taltz Ai Ifu 5 V3)

Instructional illustration showing a hand holding an injection pen administering a subcutaneous injection into the thigh area. The image demonstrates proper injection technique for a solution dosage form, likely representing the TALTZ (ixekizumab) injection.*

FDA Label Image

Figure (Taltz Ai Ifu 6 V3)

An instructional illustration depicting how to prepare an injection using a TALTZ prefilled syringe. The image shows a hand removing a cap from the syringe, and a close-up of the syringe window indicating the locked and unlocked positions of the device.*

FDA Label Image

Figure (Taltz Ai Ifu 7 V4)

An instructional illustration showing the proper use of a TALTZ (ixekizumab) prefilled injection syringe. The image demonstrates pressing the syringe against the skin, indicated by a "Click" sound, with a labeled close-up highlighting the gray plunger. A timer icon showing 10 seconds suggests how long to hold the syringe during injection.*

FDA Label Image

Figure (Taltz Ai Ifu 8 V2)

An instructional illustration showing a hand disposing of a prefilled syringe into a red sharps container, emphasizing safe injection waste disposal.*

FDA Label Image

Figure (Taltz Qr V1)

FDA Label Image

Figure (Taltz Pfsi Ifu 1)

An illustration of a syringe-like injection device, featuring a transparent barrel, a white flange with finger grips, and a green plunger handle designed for subcutaneous injection.*

FDA Label Image

Figure (Taltz Pfsi Ifu 2)

An instructional diagram of a prefilled syringe assembly showing labeled parts including thumb pad, green plunger rod, finger grips, gray syringe plunger, syringe body with medicine, needle, and needle cap. The syringe is intended for subcutaneous injection of the medication.*

FDA Label Image

Figure (Taltz Pfsi Ifu 3)

An instructional illustration showing a hand holding a syringe labeled with an arrow pointing to an area indicating the location of the syringe's expiration date. The syringe is shown with a clear barrel and a green plunger, demonstrating where to find the expiration date on the injection device.*

FDA Label Image

Figure (Taltz Pfsi Ifu 4)

An instructional illustration showing two hands preparing a syringe with a needle cap. The right hand is removing the needle cap from the syringe, indicated by a red arrow pointing to the right.*

FDA Label Image

Figure (Taltz Pfsi Ifu 5 V2)

An instructional diagram showing a hand pinching the skin with two fingers and red arrows indicating the direction of the pinch. The illustration appears designed to demonstrate the proper technique for preparing a subcutaneous injection.*

FDA Label Image

Figure (Taltz Pfsi Ifu 6 V2)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe at a 45-degree angle to the skin surface, demonstrating proper injection technique for the TALTZ injection solution.*

FDA Label Image

Figure (Taltz Pfsi Ifu 7 V2)

An illustration showing a hand injecting subcutaneously with a syringe and needle into the skin of an arm. No branding or text is visible in the image.*

FDA Label Image

Figure (Taltz Pfsi Ifu 8 V2)

An instructional illustration showing use of the TALTZ injection pen for subcutaneous administration. The top panel depicts a hand holding the injection pen against the skin with a downward motion indicated by a red arrow. The bottom panel highlights the injection pen components labeled as the green plunger rod and gray syringe plunger.*

FDA Label Image

Figure (Taltz Pfsi Ifu 9)

Illustration showing a hand holding a prefilled syringe with a green plunger, positioning the needle tip above the opening of a red sharps disposal container with a white lid, demonstrating safe injection needle disposal practice.*

FDA Label Image

Figure (Taltz 40mg Pfs Ifu 1)

An illustration showing a side view of a prefilled syringe or injector pen with a green plunger, white body, and an internal spring mechanism visible through a transparent section.*

FDA Label Image

Figure (Taltz 40mg Pfs Ifu 2)

A labeled instructional illustration of a TALTZ prefilled syringe components, including the thumb pad, green plunger rod, finger grips, syringe body with medicine, gray syringe plunger, needle, and needle cap for subcutaneous injection.*

FDA Label Image

Figure (Taltz 40mg Pfs Ifu 3)

An instructional illustration showing a hand holding a syringe with an arrow and label pointing to the area where the expiration date is located on the syringe. The syringe has a green plunger and a white barrel.*

FDA Label Image

Figure (Taltz Inj Sites 2)

An instructional diagram showing recommended subcutaneous injection sites on the human body. Highlighted areas include the abdomen, thigh, and back of the arm, illustrated on front and rear views of a human figure. The diagram is labeled as Figure B.*

FDA Label Image

Figure (Taltz 40mg Pfs Ifu 4)

An instructional illustration showing a pair of hands preparing an injection. One hand holds a syringe with a plunger, the other hand is removing a cap from the needle. A red arrow points right, indicating the direction to pull the cap off. This image demonstrates the step of uncapping the syringe for subcutaneous injection.*

FDA Label Image

Figure (Taltz 20 40 Pinch)

An instructional diagram showing a hand pinching the skin of a forearm, likely illustrating how to prepare a subcutaneous injection site. Two red arrows indicate the direction of pinching the skin with thumb and finger.*

FDA Label Image

Figure (Taltz 40mg Pfs Ifu 5)

An instructional illustration showing the subcutaneous injection technique with TALTZ (ixekizumab) injection. The image demonstrates holding the syringe at a 45-degree angle to the skin surface before injecting, with a comparison angle of 90 degrees also depicted.*

FDA Label Image

Figure (Taltz 40mg Pfs Ifu 6)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe into the skin of an arm. The syringe has a green plunger. The image demonstrates the proper angle and technique for injecting.*

FDA Label Image

Figure (Taltz 40mg Pfs Ifu 7)

An instructional diagram for TALTZ (ixekizumab) injection showing subcutaneous administration technique. Figure G illustrates a hand holding a syringe against the skin with a downward arrow indicating injection direction. Figure H shows a close-up of the syringe with labeled parts including a green plunger rod and a gray syringe plunger.*

FDA Label Image

Figure (Taltz 40mg Pfs Ifu 8)

An instructional illustration showing a hand holding a subcutaneous injection syringe above a red sharps disposal container. The syringe is positioned for disposal, indicating proper disposal technique of the injection device.*

FDA Label Image

Figure (Taltz 20mg Pfs Ifu 1)

Illustration of a TALTZ (ixekizumab) prefilled syringe designed for subcutaneous injection. The diagram shows the syringe body with a clear barrel, plunger, and needle protective cover, highlighting the injection device used for the solution dosage form.*

FDA Label Image

Figure (Taltz 20mg Pfs Ifu 2)

An instructional diagram of a syringe injection device showing labeled parts, including the thumb pad, green plunger rod, finger grips, syringe body with medicine, gray syringe plunger, needle, and needle cap. The needle cap is shown separated below the syringe.*

FDA Label Image

Figure (Taltz 20mg Pfs Ifu 3)

An instructional illustration showing a hand holding a syringe-like injection device with an arrow pointing to the window indicating the expiration date. The figure is labeled as 'Figure A'.*

FDA Label Image

Figure (Taltz 20mg Pfs Ifu 4)

An instructional illustration showing two hands holding a syringe and a needle cap. The syringe is positioned horizontally with the needle cap about to be pulled off, indicated by a red arrow pointing right. This diagram demonstrates the step of removing the cap from a syringe prior to injection.*

FDA Label Image

Figure (Taltz 20mg Pfs Ifu 5)

An instructional illustration showing the proper angle for subcutaneous injection. It depicts a hand holding a syringe at a 45-degree angle to the skin on the forearm, with a 90-degree angle also indicated for reference. The image demonstrates the technique for administering a subcutaneous injection for an injection solution like TALTZ (ixekizumab).*

FDA Label Image

Figure (Taltz 20mg Pfs Ifu 6)

An instructional illustration labeled "Figure F" showing a hand administering a subcutaneous injection into the thigh area using a syringe with a green plunger. The image visually demonstrates the proper technique for injecting a subcutaneous solution.*

FDA Label Image

Figure (Taltz 20mg Pfs Ifu 7)

Instructional illustration for administering TALTZ (ixekizumab) injection subcutaneously. The upper panel (Figure G) shows a hand pressing a green plunger rod on a syringe inserted into the skin with a red arrow indicating downward movement. The lower panel (Figure H) labels the green plunger rod and gray syringe plunger on a hand-held syringe before injection.*

FDA Label Image

Figure (Taltz 20mg Pfs Ifu 8)

An instructional illustration showing a hand holding a syringe with a green plunger, poised above a red sharps disposal container with a white lid and opening for safe needle disposal. The illustration depicts proper method for disposing of a used injection syringe, relevant for subcutaneous injection products like TALTZ (ixekizumab).*

FDA Label Image

Package Carton – Taltz Autoinjector 80 mg (Taltz Carton Ai 022 08)

Packaging label for TALTZ 80 mg/mL injection (ixekizumab) by Eli Lilly and Company. The label indicates a single-dose prefilled autoinjector for subcutaneous use. The package includes storage instructions, dosage form, strength, and manufacturer details along with a barcode and patient guide notice.*

FDA Label Image

Package Carton – Taltz Prefilled Syringe 80 mg (Taltz Carton Pfs 025 06)

TALTZ 80 mg/mL injection packaging label for subcutaneous use. The label indicates it contains 1 single-dose prefilled syringe of ixekizumab injection. It includes storage instructions, manufacturer Eli Lilly and Company, and a depiction of the syringe. The box is marked Rx only with a pharmacy label area and includes warnings and usage notes.*

FDA Label Image

Package Carton – Taltz Prefilled Syringe 40 mg (Taltz 40mg Carton Pfs 098 01)

TALTZ 40 mg/0.5 mL injection, solution for subcutaneous use, in a single-dose prefilled syringe. The packaging features the product name, generic name ixekizumab, and dosage strength prominently. It includes storage instructions, manufacturer Eli Lilly and Company, and a barcode. The box contains one single-dose prefilled syringe with directions to discard unused product.*

FDA Label Image

Package Carton – Taltz Prefilled Syringe 20 mg (Taltz 20mg Carton Pfs 099 01)

TALTZ 20 mg/0.25 mL injection, solution for subcutaneous use, by Eli Lilly and Company. The label is for a single-dose prefilled syringe containing ixekizumab. The carton design includes dosage strength, usage instructions, storage information, and regulatory details along with a syringe image and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.